Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial (PROSPECT)
Sponsor: Canadian Institutes of Health Research (CIHR)
Listed as NCT01782755, this PHASE2 trial focuses on Antibiotic-Associated Diarrhea and C-Difficile and remains completed. Sponsored by Canadian Institutes of Health Research (CIHR), it has been updated 9 times since 2013, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Sep 2019 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 4 earlier versions
-
Jun 2018 — Sep 2019 [monthly]
Completed PHASE2
-
Apr 2018 — Jun 2018 [monthly]
Completed PHASE2
-
Feb 2017 — Apr 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Institutes of Health Research (CIHR)
- Hamilton Academy of Health Science Research Organization (HAHSO)
- McMaster University
- Physician's Services Incorporated (PSI)
- Technology Evaluation in the Elderly Network (TVN)
For direct contact, visit the study record on ClinicalTrials.gov .